Item 5.07. Submission of Matters to a Vote of Security Holders.
On October 21, 2022, 9 Meters Biopharma, Inc. (the "Company") reconvened the
Company's special meeting of stockholders (the "Special Meeting"), which was
previously adjourned on September 23, 2022. At the close of business on July 25,
2022, the record date of the Special Meeting, the Company had 259,107,380 shares
of common stock issued and outstanding. The holders of a total of 131,584,292
shares of common stock eligible to vote on the record date were present at the
Special Meeting, either in person or by proxy, which constituted a quorum for
the Special Meeting. At the Special Meeting, stockholders voted on the proposal
to approve the potential issuance of shares the Company's common stock
underlying secured convertible notes in an amount that may be equal to or exceed
20% of the Company's common stock outstanding, in order to comply with Nasdaq
Listing Rule 5635(d). The final voting results for such proposal are set forth
below:
Votes For Votes Against Votes Abstained Broker Non-Votes
116,809,600 13,548,775 1,225,917 --
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses